Table A1.
Panel Member | Institution |
---|---|
Julienne E. Bower, PhD (cochair), psychology | Departments of Psychology and Psychiatry/Biobehavioral Sciences, University of California at Los Angeles, Los Angeles, CA |
Paul B. Jacobsen, PhD (cochair), psychology | H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL |
Ann Berger MSN, MD, pain and palliative care | National Institutes of Health Clinical Center, Bethesda, MD |
William Breitbart, MD, psychiatry | Memorial Sloan-Kettering Cancer Center, New York, NY |
Carmelita P. Escalante, MD, internal medicine | University of Texas MD Anderson Cancer Center, Houston, TX |
Patricia A. Ganz, MD, medical oncology | Schools of Medicine and Public Health, University of California at Los Angeles, Los Angeles, CA |
Hester Hill Schnipper, LICSW, BCD, patient representative, oncology social work | Beth Israel Deaconess Medical Center, Boston, MA |
Jennifer A. Ligibel, MD, medical oncology | Dana-Farber Cancer Institute, Boston, MA |
Gary H. Lyman, MD, MPH, FASCO, FRCP, medical oncology | Duke University and Duke Cancer Institute, Durham, NC |
Mohammed S. Ogaily, MD, FACP, ASCO PGIN representative, medical oncology | Oakwood Center for Hematology and Oncology–Downriver, Brownstown, MI |
William F. Pirl, MD, psychiatry | Massachusetts General Hospital, Boston, MA |
Kate Bak, MSc | ASCO, Alexandria, VA |
Christina Lacchetti, MHSc | ASCO, Alexandria, VA |
Abbreviations: ASCO, American Society of Clinical Oncology; PGIN, Practice Guidelines Implementation Network.